ARWR Short Information Arrowhead Pharmaceuticals Inc.

Twenty Trading Day Totals
Total Shorted Volume	1,965,311
Total Actual Volume	16,447,274

Averages
Average Short Volume	98,266
Average Short Percentage	52.93%

Is there a ARWR Short Squeeze or Breakout about to happen?

See the ARWR Short Analysis for free Sign up or Login

Stock Date	Open Price	Close Price	High	Low	Total Volume	Short Volume	Short Percentage
2022-09-27	30.3	31.2	31.34	30.04	1,049,723	120,685	51.4868
2022-09-26	30.86	29.63	31.88	29.6	798,386	83,735	39.1941
2022-09-23	31.1	30.93	31.56	30.345	841,884	76,452	32.4121
2022-09-22	32.16	31.5	32.45	31.21	637,617	64,964	55.5072
2022-09-21	34.01	32.48	34.1	32.42	689,964	56,017	44.5974
2022-09-20	34.05	33.84	34.33	32.91	772,220	108,003	64.5102
2022-09-19	34.31	34.3	34.52	33.22	781,039	106,767	49.3335
2022-09-16	35.1	34.59	35.1	33.59	1,907,908	184,148	55.7698
2022-09-15	35.18	35.13	35.68	34.44	647,810	78,620	55.6554
2022-09-14	36.1	35.27	36.1	34.4	899,961	108,460	54.6610
2022-09-13	38.21	35.9	38.35	35.61	1,285,966	180,930	56.8265
2022-09-12	38.57	39.6	39.8899	38.09	733,234	136,888	63.0057
2022-09-09	38.65	38.57	39	38.11	638,818	70,304	46.5167
2022-09-08	38.37	39.17	39.6899	38.19	696,349	69,190	48.3511
2022-09-07	37.42	39.17	39.275	37.42	837,428	120,047	59.2272
2022-09-06	39.38	37.22	39.56	37.06	631,698	99,262	60.4350
2022-09-01	39.15	41.29	41.34	38.5	644,678	93,447	63.1211
2022-08-31	38.91	39.71	40.15	38.37	967,171	98,534	55.3770
2022-08-30	39.87	38.24	40.2	37.42	559,487	64,672	52.3054
2022-08-29	39.08	39.22	40.53	38.9	425,933	44,186	50.2731

Stock Information

Arrowhead Pharmaceuticals Inc. Company Name:

ARWR Stock Symbol:

NASDAQ Market:

Get ARWR Alerts

News, Short Squeeze, Breakout and More Instantly...

ARWR - Arrowhead Pharmaceuticals to Participate in Upcoming September 2022 Conferences

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it is scheduled to participate in the following upcoming events: European Respiratory Society (ERS) International Congress 2022 – September 4-6, 2022 Title: Silencing MMP7 expression with a lung-tar...
ARWR - Arrowhead Files for Regulatory Clearance to Initiate Phase 1/2a Study of ARO-MMP7 for Idiopathic Pulmonary Fibrosis

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it has filed an application for clearance to initiate a Phase 1/2a clinical trial of ARO-MMP7, the company’s investigational RNA interference (RNAi) therapeutic designed to reduce expression of matrix metalloprote...
ARWR - Arrowhead Pharmaceuticals (ARWR) Q3 2022 Earnings Call Transcript

Image source: The Motley Fool. Arrowhead Pharmaceuticals (NASDAQ: ARWR) Q3 2022 Earnings Call Aug 04, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: Arrowhead Pharmaceuticals (ARWR) Q3 2022 Earnings Call Transcript...